REIMBURSEMENT ISSUES
... A reduced response to a drug is called tolerance. An adverse drug reaction is a harmful, unintended reaction to a drug administered at a normal dosage. Contraindications are conditions under which the drug should not be given. Interactions are modifications of the effect of a drug when administered ...
... A reduced response to a drug is called tolerance. An adverse drug reaction is a harmful, unintended reaction to a drug administered at a normal dosage. Contraindications are conditions under which the drug should not be given. Interactions are modifications of the effect of a drug when administered ...
Fractions
... A reduced response to a drug is called tolerance. An adverse drug reaction is a harmful, unintended reaction to a drug administered at a normal dosage. Contraindications are conditions under which the drug should not be given. Interactions are modifications of the effect of a drug when administered ...
... A reduced response to a drug is called tolerance. An adverse drug reaction is a harmful, unintended reaction to a drug administered at a normal dosage. Contraindications are conditions under which the drug should not be given. Interactions are modifications of the effect of a drug when administered ...
Dronabinol and Marijuana in HIV
... with HIV constitute the largest group using cannabinoids for medicinal reasons, and a considerable proportion of those with HIV currently smoke marijuana.1,2 Among HIV patients sampled in American and English medical clinics, 20% to 23% reported current marijuana use,3,4 whereas the incidence in Can ...
... with HIV constitute the largest group using cannabinoids for medicinal reasons, and a considerable proportion of those with HIV currently smoke marijuana.1,2 Among HIV patients sampled in American and English medical clinics, 20% to 23% reported current marijuana use,3,4 whereas the incidence in Can ...
Diclofenac Sodium 4% Spray Gel
... There is insufficient experience for the use during pregnancy and lactation. Therefore the use is not recommended. Use in pregnancy: No evidence of a malformative effect was observed with diclofenac. However, additional epidemiological data is necessary to assess safety. During the last trimester of ...
... There is insufficient experience for the use during pregnancy and lactation. Therefore the use is not recommended. Use in pregnancy: No evidence of a malformative effect was observed with diclofenac. However, additional epidemiological data is necessary to assess safety. During the last trimester of ...
acetaminophen and codeine phosphate tablets
... opioid adverse reactions such as nausea, vomiting, CNS effects, and respiratory depression. In opioid-tolerant patients, the situation may be altered by the development of tolerance to opioid-related adverse reactions (see DOSAGE AND ADMINISTRATION). Pharmacokinetics The behavior of the individual c ...
... opioid adverse reactions such as nausea, vomiting, CNS effects, and respiratory depression. In opioid-tolerant patients, the situation may be altered by the development of tolerance to opioid-related adverse reactions (see DOSAGE AND ADMINISTRATION). Pharmacokinetics The behavior of the individual c ...
Cannabis Report of the Swiss Federal Commission For Drug Issues
... In the course of its initial meetings, the Federal Commission for Drug Issues (EKDF) mandated by the Swiss Federal Council in early 1997 drew up an assessment of the situation regarding drugs in Switzerland and of the current need for action. Its predecessor (the Subcommission for Drug Issues attach ...
... In the course of its initial meetings, the Federal Commission for Drug Issues (EKDF) mandated by the Swiss Federal Council in early 1997 drew up an assessment of the situation regarding drugs in Switzerland and of the current need for action. Its predecessor (the Subcommission for Drug Issues attach ...
Therapeutic monitoring of vancomycin in adult patients
... and pharmacodynamic monitoring parameters have been proposed for vancomycin, including time (t) the concentration of vancomycin remains above the minimum inhibitory concentration (MIC), the ratio of the area under the serum drug concentration-versus-time curve and the MIC, and the ratio of the maxim ...
... and pharmacodynamic monitoring parameters have been proposed for vancomycin, including time (t) the concentration of vancomycin remains above the minimum inhibitory concentration (MIC), the ratio of the area under the serum drug concentration-versus-time curve and the MIC, and the ratio of the maxim ...
CLARITIN® Rapid Dissolve
... evaluated in three clinical pharmacologic studies using a histamine-induced skin wheal suppression model in healthy male volunteers. All doses were significantly more effective than placebo in suppressing the formation of histamine-induced skin wheals (See DETAILED PHARMACOLOGY / Human Pharmacology) ...
... evaluated in three clinical pharmacologic studies using a histamine-induced skin wheal suppression model in healthy male volunteers. All doses were significantly more effective than placebo in suppressing the formation of histamine-induced skin wheals (See DETAILED PHARMACOLOGY / Human Pharmacology) ...
11146027
... sample. It is notable that most of the analytical tests are based on measuring specified components in the presence of a sample matrix and/or related substances and consequently isolation or separation of the target analytes preceding quantitative and qualitative analysis becomes compulsory. By usin ...
... sample. It is notable that most of the analytical tests are based on measuring specified components in the presence of a sample matrix and/or related substances and consequently isolation or separation of the target analytes preceding quantitative and qualitative analysis becomes compulsory. By usin ...
idarubicin
... idarubicin total cumulative doses up to 400 mg/m2 suggest a low probability of cardiotoxicity. Cardiac function should be assessed before patients undergo treatment with idarubicin and must be monitored throughout therapy to minimize the risk of incurring severe cardiac impairment. The risk may be d ...
... idarubicin total cumulative doses up to 400 mg/m2 suggest a low probability of cardiotoxicity. Cardiac function should be assessed before patients undergo treatment with idarubicin and must be monitored throughout therapy to minimize the risk of incurring severe cardiac impairment. The risk may be d ...
Poisoning and Drug Overdose
... reliable in their efforts to provide information that is complete and generally in accord with the standards accepted at the time of publication. However, in view of the possibility of human error or changes in medical sciences, neither the authors nor the publisher nor any other party who has been ...
... reliable in their efforts to provide information that is complete and generally in accord with the standards accepted at the time of publication. However, in view of the possibility of human error or changes in medical sciences, neither the authors nor the publisher nor any other party who has been ...
Position Paper: Ipecac Syrup
... Eleven volunteer studies have investigated the value of ipecac in preventing the absorption of marker substances (5 –15). In these studies, the recovery of material was highly variable, though generally the amount of ingested material removed by ipecac-induced emesis depended on the elapsed time bet ...
... Eleven volunteer studies have investigated the value of ipecac in preventing the absorption of marker substances (5 –15). In these studies, the recovery of material was highly variable, though generally the amount of ingested material removed by ipecac-induced emesis depended on the elapsed time bet ...
BIOAVAILABILITY ENHANCEMENT TECHNIQUES OF HERBAL MEDICINE: A CASE EXAMPLE OF CURCUMIN
... via enhanced permeability and retention effects. Although the remove of β-diketone moiety made curcumin more stable, β-diketone may be necessary for the biological activities of curcumin for some treatments. Some previous studies suggested that the presence of the β-diketone moiety may be necessary ...
... via enhanced permeability and retention effects. Although the remove of β-diketone moiety made curcumin more stable, β-diketone may be necessary for the biological activities of curcumin for some treatments. Some previous studies suggested that the presence of the β-diketone moiety may be necessary ...
Lopinavir/Ritonavir
... Lopinavir is a novel protease inhibitor (PI) developed from ritonavir. Coadministration with low-dose ritonavir significantly improves the pharmacokinetic properties and hence the activity of lopinavir against HIV-1 protease. Coformulated lopinavir/ritonavir was developed for ease of administration ...
... Lopinavir is a novel protease inhibitor (PI) developed from ritonavir. Coadministration with low-dose ritonavir significantly improves the pharmacokinetic properties and hence the activity of lopinavir against HIV-1 protease. Coformulated lopinavir/ritonavir was developed for ease of administration ...
Contributions of CYP3A4, P-glycoprotein, and Serum Protein
... due to a reduced unbound concentration of drug after it enters the portal circulation. The human intestinal cell line Caco-2 forms polarized monolayers that structurally resemble enterocytes (Meunier et al., 1995). Although these cells constitutively express several drug-metabolizing enzymes and tra ...
... due to a reduced unbound concentration of drug after it enters the portal circulation. The human intestinal cell line Caco-2 forms polarized monolayers that structurally resemble enterocytes (Meunier et al., 1995). Although these cells constitutively express several drug-metabolizing enzymes and tra ...
Lupaneta Pack
... Because norethindrone acetate may cause some degree of fluid retention, carefully observe women with conditions that might be influenced by this effect, such as epilepsy, migraine, cardiac or renal dysfunctions. 5.9 Convulsions There have been postmarketing reports of convulsions in patients on leup ...
... Because norethindrone acetate may cause some degree of fluid retention, carefully observe women with conditions that might be influenced by this effect, such as epilepsy, migraine, cardiac or renal dysfunctions. 5.9 Convulsions There have been postmarketing reports of convulsions in patients on leup ...
Handbook of Pharmaceutical Excipients, 7th ed. Sample chapter.
... Laxative effects may occur if mannitol is consumed orally in large quantities.(27) If it is used in foods as a bodying agent and daily ingestion of over 20 g is foreseeable, the product label should bear the statement ‘excessive consumption may have a laxative effect’. After intravenous injection, m ...
... Laxative effects may occur if mannitol is consumed orally in large quantities.(27) If it is used in foods as a bodying agent and daily ingestion of over 20 g is foreseeable, the product label should bear the statement ‘excessive consumption may have a laxative effect’. After intravenous injection, m ...
Cytochrome P450 2D6 (CYP2D6) Pharmacogenetic
... • CYP2D6 is an enzyme that metabolizes many commonly prescribed drugs • Metabolism by CYP2D6 can either activate or inactivate a drug: – Codeine is a prodrug that is metabolized to an active form (morphine) by CYP2D6 – Amitriptyline is metabolized by CYP2D6 to a less active form ...
... • CYP2D6 is an enzyme that metabolizes many commonly prescribed drugs • Metabolism by CYP2D6 can either activate or inactivate a drug: – Codeine is a prodrug that is metabolized to an active form (morphine) by CYP2D6 – Amitriptyline is metabolized by CYP2D6 to a less active form ...
Clinical and pharmacological evaluation of buprenorphine and
... same combination was taken illicitly by a parenteral route, it would have the opposite effects, precipitating substantial opiate withdrawal. This was an unusual requirement for a new drug formulation. In general, successful medications do not produce unpleasant effects and exhibit minimal interindiv ...
... same combination was taken illicitly by a parenteral route, it would have the opposite effects, precipitating substantial opiate withdrawal. This was an unusual requirement for a new drug formulation. In general, successful medications do not produce unpleasant effects and exhibit minimal interindiv ...
LUPANETA PACK
... Because norethindrone acetate may cause some degree of fluid retention, carefully observe women with conditions that might be influenced by this effect, such as epilepsy, migraine, cardiac or renal dysfunctions. 5.9 Convulsions There have been postmarketing reports of convulsions in patients on leup ...
... Because norethindrone acetate may cause some degree of fluid retention, carefully observe women with conditions that might be influenced by this effect, such as epilepsy, migraine, cardiac or renal dysfunctions. 5.9 Convulsions There have been postmarketing reports of convulsions in patients on leup ...
Drug utilisation sub-committee (DUSC)
... therapies co administered with ezetimibe products. The analyses imputed drug regimens for the prevalent treated population since ezetimibe was first available (August 2004). The methodology is fully described in Appendix C. All ezetimibe products are priced above the general patient copayment, howev ...
... therapies co administered with ezetimibe products. The analyses imputed drug regimens for the prevalent treated population since ezetimibe was first available (August 2004). The methodology is fully described in Appendix C. All ezetimibe products are priced above the general patient copayment, howev ...
METHOTREXATE 25 MG/ML SOLUTION FOR INJECTION
... The application and dosage recommendations for the administration of methotrexate (low-dose therapy, mostly as part of polychemotherapy) for different indications varies considerably. Some common dosages and therapy protocols, which have proved to be efficacious in the therapy of the disorder in eac ...
... The application and dosage recommendations for the administration of methotrexate (low-dose therapy, mostly as part of polychemotherapy) for different indications varies considerably. Some common dosages and therapy protocols, which have proved to be efficacious in the therapy of the disorder in eac ...
Statins - Amazon Web Services
... 607 000 lives, translating into about 1 out of every 5 deaths in the United States.1 High levels of cholesterol, or hypercholesterolemia, are an important risk factor for coronary heart disease. The 3-hydroxy-3-methylglutaryl-coenzyme (HMG-CoA) reductase inhibitors, also known as statins, are the mo ...
... 607 000 lives, translating into about 1 out of every 5 deaths in the United States.1 High levels of cholesterol, or hypercholesterolemia, are an important risk factor for coronary heart disease. The 3-hydroxy-3-methylglutaryl-coenzyme (HMG-CoA) reductase inhibitors, also known as statins, are the mo ...
Drug Class Review HMG-CoA Reductase Inhibitors (Statins) and
... 607 000 lives, translating into about 1 out of every 5 deaths in the United States.1 High levels of cholesterol, or hypercholesterolemia, are an important risk factor for coronary heart disease. The 3-hydroxy-3-methylglutaryl-coenzyme (HMG-CoA) reductase inhibitors, also known as statins, are the mo ...
... 607 000 lives, translating into about 1 out of every 5 deaths in the United States.1 High levels of cholesterol, or hypercholesterolemia, are an important risk factor for coronary heart disease. The 3-hydroxy-3-methylglutaryl-coenzyme (HMG-CoA) reductase inhibitors, also known as statins, are the mo ...
Pharmacokinetics
Pharmacokinetics, sometimes abbreviated as PK (from Ancient Greek pharmakon ""drug"" and kinetikos ""moving, putting in motion""; see chemical kinetics), is a branch of pharmacology dedicated to determining the fate of substances administered externally to a living organism. The substances of interest include pharmaceutical agents, hormones, nutrients, and toxins. It attempts to discover the fate of a drug from the moment that it is administered up to the point at which it is completely eliminated from the body.Pharmacokinetics describes how the body affects a specific drug after administration through the mechanisms of absorption and distribution, as well as the chemical changes of the substance in the body (e.g. by metabolic enzymes such as cytochrome P450 or glucuronosyltransferase enzymes), and the effects and routes of excretion of the metabolites of the drug. Pharmacokinetic properties of drugs may be affected by elements such as the site of administration and the dose of administered drug. These may affect the absorption rate. Pharmacokinetics is often studied in conjunction with pharmacodynamics, the study of a drug's pharmacological effect on the body.A number of different models have been developed in order to simplify conceptualization of the many processes that take place in the interaction between an organism and a drug. One of these models, the multi-compartment model, gives the best approximation to reality; however, the complexity involved in using this type of model means that monocompartmental models and above all two compartmental models are the most-frequently used. The various compartments that the model is divided into are commonly referred to as the ADME scheme (also referred to as LADME if liberation is included as a separate step from absorption): Liberation - the process of release of a drug from the pharmaceutical formulation. See also IVIVC. Absorption - the process of a substance entering the blood circulation. Distribution - the dispersion or dissemination of substances throughout the fluids and tissues of the body. Metabolization (or biotransformation, or inactivation) – the recognition by the organism that a foreign substance is present and the irreversible transformation of parent compounds into daughter metabolites. Excretion - the removal of the substances from the body. In rare cases, some drugs irreversibly accumulate in body tissue.The two phases of metabolism and excretion can also be grouped together under the title elimination.The study of these distinct phases involves the use and manipulation of basic concepts in order to understand the process dynamics. For this reason in order to fully comprehend the kinetics of a drug it is necessary to have detailed knowledge of a number of factors such as: the properties of the substances that act as excipients, the characteristics of the appropriate biological membranes and the way that substances can cross them, or the characteristics of the enzyme reactions that inactivate the drug.All these concepts can be represented through mathematical formulas that have a corresponding graphical representation. The use of these models allows an understanding of the characteristics of a molecule, as well as how a particular drug will behave given information regarding some of its basic characteristics. Such as its acid dissociation constant (pKa), bioavailability and solubility, absorption capacity and distribution in the organism.The model outputs for a drug can be used in industry (for example, in calculating bioequivalence when designing generic drugs) or in the clinical application of pharmacokinetic concepts. Clinical pharmacokinetics provides many performance guidelines for effective and efficient use of drugs for human-health professionals and in veterinary medicine.